Four private equities now targeting Stada

Private equities Advent and Permira are ready to place their bids for Germany-based pharmaceutical group Stada, valued at approximately €4.8bn, Reuters reported, citing people familiar with the matter. Private equities Bain Capital and Cinven also have a strong interest in Stada, according to news already circulating before. The firms would consider an offer of up to €60 per share, which would represent a premium 5% over yesterday’s closing price. (Source Reuters)